- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- FUC- NAG: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
CA.2: 4 residues within 4Å:- Chain A: D.158, D.160, S.162, N.164
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.158, A:D.158, A:D.160, A:N.164, H2O.2
CA.7: 4 residues within 4Å:- Chain B: D.158, D.160, S.162, N.164
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.158, B:D.158, B:D.160, B:N.164, H2O.9
CA.12: 4 residues within 4Å:- Chain C: D.158, D.160, S.162, N.164
5 PLIP interactions:4 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.158, C:D.158, C:D.160, C:N.164, H2O.15
CA.17: 4 residues within 4Å:- Chain D: D.158, D.160, S.162, N.164
5 PLIP interactions:4 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.158, D:D.158, D:D.160, D:N.164, H2O.22
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: F.61, R.62, G.63, A.66, K.155
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:G.63
- Water bridges: A:N.59, A:A.66
- Salt bridges: A:R.62, A:K.155
SO4.8: 5 residues within 4Å:- Chain B: F.61, R.62, G.63, A.66, K.155
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:G.63
- Water bridges: B:N.59, B:A.66
- Salt bridges: B:R.62, B:K.155
SO4.13: 5 residues within 4Å:- Chain C: F.61, R.62, G.63, A.66, K.155
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:G.63
- Water bridges: C:N.59, C:A.66
- Salt bridges: C:R.62, C:K.155
SO4.18: 5 residues within 4Å:- Chain D: F.61, R.62, G.63, A.66, K.155
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:G.63
- Water bridges: D:N.59, D:A.66
- Salt bridges: D:R.62, D:K.155
- 4 x ACY: ACETIC ACID(Non-functional Binders)
ACY.4: 2 residues within 4Å:- Chain A: A.168, R.171
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.171
ACY.9: 2 residues within 4Å:- Chain B: A.168, R.171
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.171
ACY.14: 2 residues within 4Å:- Chain C: A.168, R.171
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:R.171
ACY.19: 2 residues within 4Å:- Chain D: A.168, R.171
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:R.171
- 4 x SLB: N-acetyl-beta-neuraminic acid(Non-covalent)
SLB.5: 7 residues within 4Å:- Chain A: Y.170, N.178, C.179, H.180, Y.196, A.197, W.208
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:Y.170, A:Y.196, A:A.197, A:W.208
- Hydrogen bonds: A:Y.170, A:N.178, A:C.179, A:H.180, A:Y.196, A:Y.196, A:Y.196
- Water bridges: A:Y.170, A:N.178
SLB.10: 7 residues within 4Å:- Chain B: Y.170, N.178, C.179, H.180, Y.196, A.197, W.208
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:Y.170, B:Y.196, B:A.197, B:W.208
- Hydrogen bonds: B:Y.170, B:N.178, B:C.179, B:H.180, B:Y.196, B:Y.196, B:Y.196
- Water bridges: B:Y.170, B:N.178
SLB.15: 7 residues within 4Å:- Chain C: Y.170, N.178, C.179, H.180, Y.196, A.197, W.208
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:Y.170, C:Y.196, C:A.197, C:W.208
- Hydrogen bonds: C:Y.170, C:N.178, C:C.179, C:H.180, C:Y.196, C:Y.196, C:Y.196
- Water bridges: C:Y.170, C:N.178
SLB.20: 7 residues within 4Å:- Chain D: Y.170, N.178, C.179, H.180, Y.196, A.197, W.208
13 PLIP interactions:13 interactions with chain D- Hydrophobic interactions: D:Y.170, D:Y.196, D:A.197, D:W.208
- Hydrogen bonds: D:Y.170, D:N.178, D:C.179, D:H.180, D:Y.196, D:Y.196, D:Y.196
- Water bridges: D:Y.170, D:N.178
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Williams, H.M. et al., Crystal structures of human immune protein FIBCD1 suggest an extended binding site compatible with recognition of pathogen associated carbohydrate motifs. J.Biol.Chem. (2023)
- Release Date
- 2021-07-21
- Peptides
- Fibrinogen C domain-containing protein 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- FUC- NAG: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 4 x ACY: ACETIC ACID(Non-functional Binders)
- 4 x SLB: N-acetyl-beta-neuraminic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Williams, H.M. et al., Crystal structures of human immune protein FIBCD1 suggest an extended binding site compatible with recognition of pathogen associated carbohydrate motifs. J.Biol.Chem. (2023)
- Release Date
- 2021-07-21
- Peptides
- Fibrinogen C domain-containing protein 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A